83 related articles for article (PubMed ID: 33645526)
1. [Methylation profiles of genes in breast cancer luminal HER2-negative primary tumor during regional lymphnode metastasis].
Krasnyi AM; Kurevlev SV; Sadekova AA; Sefikhanov TG; Kometova VV; Rodionov VV
Biomed Khim; 2021 Jan; 67(1):88-94. PubMed ID: 33645526
[TBL] [Abstract][Full Text] [Related]
2. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients.
Laurberg T; Alsner J; Tramm T; Jensen V; Lyngholm CD; Christiansen PM; Overgaard J
Acta Oncol; 2017 Jan; 56(1):59-67. PubMed ID: 27846764
[TBL] [Abstract][Full Text] [Related]
3. Methylation signature of lymph node metastases in breast cancer patients.
Barekati Z; Radpour R; Lu Q; Bitzer J; Zheng H; Toniolo P; Lenner P; Zhong XY
BMC Cancer; 2012 Jun; 12():244. PubMed ID: 22695536
[TBL] [Abstract][Full Text] [Related]
4. Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good Prognosis.
Madera S; Chervo MF; Chiauzzi VA; Pereyra MG; Venturutti L; Izzo F; Roldán Deamicis A; Guzman P; Dupont A; Roa JC; Cenciarini ME; Barchuk S; Figurelli S; Lopez Della Vecchia D; Levit C; Lebersztein G; Anfuso F; Castiglioni T; Cortese E; Ares S; Deza EG; Gercovich FG; Proietti CJ; Schillaci R; Cordo Russo RI; Elizalde PV
Horm Cancer; 2020 Oct; 11(5-6):218-239. PubMed ID: 32632815
[TBL] [Abstract][Full Text] [Related]
5. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B
Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661
[TBL] [Abstract][Full Text] [Related]
6. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
7. Impact of
Jezkova E; Zubor P; Kajo K; Grendar M; Dokus K; Adamkov M; Lasabova Z; Plank L; Danko J
Oncol Lett; 2017 Jul; 14(1):758-766. PubMed ID: 28693231
[TBL] [Abstract][Full Text] [Related]
8. Discordance Rate in Estrogen Receptor, Progesterone Receptor, HER2 Status, and Ki67 Index Between Primary Unifocal and Multiple Homogenous Breast Carcinomas and Synchronous Axillary Lymph Node Metastases Have an Impact on Therapeutic Decision.
Georgescu R; Boros M; Moncea D; Bauer O; Coros MF; Oprea A; Moldovan C; Podoleanu C; Stolnicu S
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):533-538. PubMed ID: 28099174
[TBL] [Abstract][Full Text] [Related]
9. Comparison Between HER2, Estrogen Receptors and Progesterone Receptors in Primary Breast Carcinomas and Matched Lymph Node Metastases.
Desouki MM; Atta IS; Wolff DJ; Self SE
Turk Patoloji Derg; 2016; 32(3):178-85. PubMed ID: 27562392
[TBL] [Abstract][Full Text] [Related]
10. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
Sebova K; Zmetakova I; Bella V; Kajo K; Stankovicova I; Kajabova V; Krivulcik T; Lasabova Z; Tomka M; Galbavy S; Fridrichova I
Cancer Biomark; 2011-2012; 10(1):13-26. PubMed ID: 22297548
[TBL] [Abstract][Full Text] [Related]
11. Hormone receptors and HER2 expression in primary breast carcinoma and corresponding lymph node metastasis: do we need both?
Raica M; Cîmpean AM; Ceausu RA; Fulga V; Nica C; Rudico L; Saptefrati L
Anticancer Res; 2014 Mar; 34(3):1435-40. PubMed ID: 24596391
[TBL] [Abstract][Full Text] [Related]
12. Correlation between CpG methylation profiles and hormone receptor status in breast cancers.
Feng W; Shen L; Wen S; Rosen DG; Jelinek J; Hu X; Huan S; Huang M; Liu J; Sahin AA; Hunt KK; Bast RC; Shen Y; Issa JP; Yu Y
Breast Cancer Res; 2007; 9(4):R57. PubMed ID: 17764565
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
Liu ZF; Chen C; Yao XL; Sun SR
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
[TBL] [Abstract][Full Text] [Related]
14. The Case to Case Comparison of Hormone Receptors and HER2 Status between Primary Breast Cancer and Synchronous Axillary Lymph Node Metastasis.
Sujarittanakarn S; Himakhun W; Worasawate W; Prasert W
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1559-1565. PubMed ID: 32592349
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic variations in breast cancer progression to lymph node metastasis.
Urrutia G; Laurito S; Marzese DM; Gago F; Orozco J; Tello O; Branham T; Campoy EM; Roqué M
Clin Exp Metastasis; 2015 Feb; 32(2):99-110. PubMed ID: 25628026
[TBL] [Abstract][Full Text] [Related]
17. Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?
Falck AK; Fernö M; Bendahl PO; Rydén L
World J Surg; 2010 Jul; 34(7):1434-41. PubMed ID: 20213203
[TBL] [Abstract][Full Text] [Related]
18. Frequent Molecular Subtype Switching and Gene Expression Alterations in Lung and Pleural Metastasis From Luminal A-Type Breast Cancer.
Klebe M; Fremd C; Kriegsmann M; Kriegsmann K; Albrecht T; Thewes V; Kirchner M; Charoentong P; Volk N; Haag J; Wirtz R; Oskarsson T; Schulz A; Heil J; Schneeweiss A; Winter H; Sinn P
JCO Precis Oncol; 2020; 4():. PubMed ID: 32923902
[TBL] [Abstract][Full Text] [Related]
19. Association between molecular subtypes and lymph node status in invasive breast cancer.
Si C; Jin Y; Wang H; Zou Q
Int J Clin Exp Pathol; 2014; 7(10):6800-6. PubMed ID: 25400761
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review.
Huang R; Ding P; Yang F
Drug Des Devel Ther; 2015; 9():5277-85. PubMed ID: 26425077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
